Probiotic
attenuates
Common Cold
Probiotic
attenuates
Common Cold
4.8
ValidityScore
Valid or Invalid?
-
2014Meta-Analysis
-
Fitzgerald A, Glanville J, King S, Sanders ME, Varley D -
«Meta-analysis revealed significantly fewer numbers of days of illness per person (standardised mean difference (SMD) - 0·31 (95% CI - 0·41, - 0·11), I²= 3%), shorter illness episodes by almost a day (weight mean difference - 0·77 (95% CI - 1·50, - 0·04), I²= 80%) (without an increase in the number of illness episodes), and fewer numbers of days absent from day care/school/work (SMD - 0·17 (95% CI - 0·31, - 0·03), I²= 67%) in participants who received a probiotic intervention than in those who had taken a placebo. »
- Organism: Humans
- Minor Magnitude of Effect.
-
#10.1017/S0007114514000075, 24780623, Acute Disease, Adult, Anti-Infective Agents / therapeutic use, Bifidobacterium / immunology, Child, Danielle Varley, Disease Resistance, Evidence-Based Medicine, Humans, Immunity, Julie Glanville, Lactobacillus / immunology, MEDLINE, Mucosal, NCBI, NIH, NLM, National Center for Biotechnology Information, National Institutes of Health, National Library of Medicine, PMC4054664, Probiotics / therapeutic use, PubMed Abstract, Randomized Controlled Trials as Topic, Respiratory Mucosa / immunology, Respiratory Tract Infections / diet therapy, Respiratory Tract Infections / immunology, Respiratory Tract Infections / prevention &, Sarah King, Time Factors, controlmore... -
ranked
added it
3 years ago
on Mar 11, 2020